Form 8-K - Current report:
SEC Accession No. 0001104659-26-091266
Filing Date
2026-08-05
Accepted
2026-08-05 17:16:01
Documents
18
Period of Report
2026-07-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2621363d5_8k.htm   iXBRL 8-K 73928
2 EXHIBIT 10.1 tm2621363d5_10-1.htm EX-10.1 656553
3 EXHIBIT 10.2 tm2621363d5_10-2.htm EX-10.2 30727
4 EXHIBIT 10.3 tm2621363d5_10-3.htm EX-10.3 98274
5 EXHIBIT 10.4 tm2621363d5_10-4.htm EX-10.4 653400
6 EXHIBIT 10.5 tm2621363d5_10-5.htm EX-10.5 27016
7 EXHIBIT 10.6 tm2621363d5_10-6.htm EX-10.6 90745
8 EXHIBIT 99.1 tm2621363d5_ex99-1.htm EX-99.1 19969
  Complete submission text file 0001104659-26-091266.txt   2181754

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vreof-20260730.xsd EX-101.SCH 3026
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vreof-20260730_lab.xml EX-101.LAB 34239
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vreof-20260730_pre.xml EX-101.PRE 22365
22 EXTRACTED XBRL INSTANCE DOCUMENT tm2621363d5_8k_htm.xml XML 2873
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Vireo Growth Inc. (Filer) CIK: 0001771706 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 261244835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)